EP3672631
LYFJASAMSETNING SEM INNIHELDUR AND-BETA-MÝLILDIS-MÓTEFNI
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
22.8.2018EP published:
29.3.2023EP application number:
18762749.2
EP translation filed:
28.6.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
21.8.2038Expiry date:
21.8.2026Next due date:
31.8.2026
Title in English:
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIESLanguage of the patent:
English
Timeline
Today
22.8.2018EP application
29.3.2023EP Publication
28.6.2023Translation submitted
15.8.2023Registration published
21.8.2026Expires
Owner
Name:
Biogen MA Inc.Address:
225 Binney Street, Cambridge, MA 02142, US
Inventor
Name:
LANTZ, Steven AndrewAddress:
Cambridge Massachusetts 02142, US
Name:
GUPTA, KapilAddress:
Cambridge Massachusetts 02142, US
Name:
SULE, ShantanuAddress:
Cambridge Massachusetts 02142, US
Name:
ZUNIC, AdnanAddress:
Cambridge Massachusetts 02142, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201762548583 PDate:
22.8.2017Country:
US
Classification
Categories:
A61K 39/395, C07K 16/18
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.7.2023
Expires: 21.8.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 23.7.2024
Expires: 21.8.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.8.2025
Expires: 21.8.2026
Payer: Árnason Faktor ehf.